Target intelligence / Profile preview

Physiological bile acid and bilirubin homeostasis

Molecular classification
Other
01

Overview

Physiological bile acid and bilirubin homeostasis refers to the integrated regulatory network responsible for the synthesis, transport, and excretion of bile salts and heme degradation products [Physiological Reviews, 2003]. This system is not a single molecular target but a coordinated pathway involving nuclear receptors like the Farnesoid X Receptor (FXR), enzymes such as UDP-glucuronosyltransferase 1A1 (UGT1A1), and various hepatic transporters including OATP1B1 and BSEP [Hepatology, 2009; Pharmacological Reviews, 2010]. Bile acids are essential for the emulsification of dietary lipids and act as signaling molecules that regulate systemic metabolism [Genes & Development, 2008]. Bilirubin, a byproduct of heme catabolism, requires efficient conjugation by UGT1A1 and transport by MRP2 to prevent toxic accumulation [StatPearls, 2023]. Dysregulation of these processes leads to pathological conditions such as cholestasis, jaundice, and primary biliary cholangitis [The Lancet, 2018]. Pharmacological interventions typically target specific components of this network, such as using FXR agonists like obeticholic acid to reduce bile acid synthesis or enzyme inducers to enhance bilirubin clearance [NEJM, 2016].

Other names
Bile acid and bilirubin metabolismEnterohepatic circulation of bile salts and pigments
02

Mechanism of action

Regulation of bile acid and bilirubin levels through the activation of nuclear receptors (e.g., FXR), induction of conjugating enzymes (e.g., UGT1A1), and modulation of hepatic transporters (e.g., OATPs, BSEP, MRP2) [Physiological Reviews, 2003; StatPearls, 2023].

03

Biological functions

MetabolismHomeostasisTransportDetoxificationLipid digestion
04

Disease associations

CholestasisHyperbilirubinemiaJaundicePrimary biliary cholangitisNon-alcoholic steatohepatitis
05

Safety considerations

HepatotoxicityPruritusDrug-drug interactions via transporter inhibitionKernicterus risk
06

Interacting drugs

Obeticholic acid

4 more in the full profile.

07

Biomarkers

Serum total bilirubinSerum bile acidsAlkaline phosphatase (ALP)Gamma-glutamyl transferase (GGT)

Beyond the preview

Go deeper on Physiological bile acid and bilirubin homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological bile acid and bilirubin homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call